$10.25
+0.410 (+4.17%)
At Close: Jun 03, 2026
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
06:32pm, Wednesday, 04'th Dec 2024
Earlier this year FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease Earlier this year FDA granted REVASCOR both Rare Pe
Oddity Tech: Executing Well (Rating Upgrade)
03:30pm, Wednesday, 04'th Dec 2024
Oddity Tech's data-driven, AI-powered DTC model looks set to facilitate market share gains through FY28. ODD's forward EV/EBITDA valuation of 16.2x is pricier than the industry average, but we feel it
This AI Stock Picks The Perfect Lipstick
01:32pm, Friday, 29'th Nov 2024
AI stock Oddity hit a new buy point this week. The Israeli retailer uses AI to deliver a precise product match to customers.
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
08:25am, Monday, 25'th Nov 2024
Investors can add these top-ranked liquid stocks, American Superconductor Corporation, Angi, Sezzle and Oddity Tech, to their portfolios to boost returns.
Oddity Tech (ODD) Recently Broke Out Above the 20-Day Moving Average
10:35am, Friday, 22'nd Nov 2024
From a technical perspective, Oddity Tech (ODD) is looking like an interesting pick, as it just reached a key level of support. ODD recently overtook the 20-day moving average, and this suggests a sho
Can Oddity Tech (ODD) Climb 28.74% to Reach the Level Wall Street Analysts Expect?
11:01am, Wednesday, 20'th Nov 2024
The mean of analysts' price targets for Oddity Tech (ODD) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analy
What Makes Oddity Tech (ODD) a New Strong Buy Stock
01:05pm, Friday, 15'th Nov 2024
Oddity Tech (ODD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
L Catterton Agrees to Sell $100 Million of Shares Back to ODDITY
05:19pm, Wednesday, 13'th Nov 2024
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced that it has entered into a transaction with a fund managed by L Catterton (“L Catterton”) to repurchase
Oddity Tech Ltd (ODD) Q3 2024 Earnings Call Transcript
10:34am, Saturday, 09'th Nov 2024
Oddity Tech Ltd (NASDAQ:ODD ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Maria Lycouris - Investor Relations Oran Holtzman - Co-Founder and Chief Executive Office
Oddity Tech (ODD) Q3 Earnings and Revenues Surpass Estimates
07:26pm, Wednesday, 06'th Nov 2024
Oddity Tech (ODD) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.21 per share a year ago.
ODD or SMAR: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 30'th Sep 2024
Investors interested in stocks from the Internet - Software sector have probably already heard of Oddity Tech (ODD) and Smartsheet (SMAR). But which of these two stocks is more attractive to value inv
The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Case Against Oddity Tech Ltd.
11:00am, Wednesday, 18'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oddity Tech Ltd. ("Oddity" o
Levi & Korsinsky Notifies ODDITY Tech Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline – ODD
06:15pm, Tuesday, 17'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / If you suffered a loss on your ODDITY Tech Ltd. (NASDAQ:ODD) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK , Sept. 17, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ODDITY Tech Ltd.
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / If you suffered a loss on your ODDITY Tech Ltd. (NASDAQ:ODD) investment and want to learn about a potential recovery under the federal securities laws,
Sign In
Buy ODD